FORA Capital’s Generation Bio GBIO Stock Holding History

FORA Capital’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-111	Closed	-$30K	–	542
2021 Q2	$30K	Buy	+111	New	+$33.2K	0.01%	782

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

FORA Capital's GBIO Position: Q3 2021 in Review

FORA Capital sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 111 shares — an estimated $30K sold.

FORA Capital first reported a position in GBIO in Q2 2021 and held it in 1 quarter. The position peaked at $30K in Q2 2021. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

FORA Capital reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 111 Generation Bio shares in Q3 2021, an estimated $30K.
FORA Capital first reported a position in Generation Bio in Q2 2021 and held it in 1 quarter.
FORA Capital's Generation Bio position peaked at $30K in Q2 2021.
81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.